Skip to main content

Table 4 Physical function and performance status of the study groups at baseline and week 12a

From: Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial

Outcome Measure Study group n Baseline Week 12 Difference week 12 p b p c
Physical function
 SMWT distance [m] Control 21 484.30 ± 135.0 504.6 ± 116.8 20.3 ± 48.2 0.024 0.036
WB-EMS 51 521.6 ± 104.5 577.1 ± 95.4 55.4 ± 75.2 < 0.001
Performance status
 Karnofsky Index Control 24 75.4 ± 10.6 73.8 ± 12.1 −1.7 ± 10.5 0.412 0.025
WB-EMS 57 76.4 ± 10.9 81.6 ± 12.4 5.2 ± 11.7 0.002
  1. Statistically significant differences are marked in bold type and indicated by p < 0.05
  2. Abbreviations: SMWT Six-minute walk test, WB-EMS Whole-body electromyostimulation
  3. aIncludes patients with both baseline and post-intervention data. Data are presented as mean ± SD
  4. bComparison of intragroup differences in baseline and post-intervention data (Wilcoxon signed-rank test)
  5. cComparison of differences from baseline to 12-week post-intervention changes between the groups (Mann-Whitney-U-test)